Aug 14, 2017
Pune, India, 14th August 2017: WiseGuyReports announced addition of new report, titled “Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017”.
Pune, India - August 14, 2017 /MarketersMedia/ —
Summary
Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver or abdomen, swollen feet and ankles and weight gain. The predisposing factors include high blood pressure, diabetes, sleep apnea, alcohol use and irregular heartbeats. Treatment includes surgery, vasodilator, beta blockers and diuretics.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1705798-congestive-heart-failure-heart-failure-pipeline-review-h2-2017
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Congestive Heart Failure (Heart Failure) (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Congestive Heart Failure (Heart Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 19, 27, 17, 2, 43, 11 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 19 and 8 molecules, respectively.
Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Congestive Heart Failure (Heart Failure) (Cardiovascular).
- The pipeline guide reviews pipeline therapeutics for Congestive Heart Failure (Heart Failure) (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Congestive Heart Failure (Heart Failure) (Cardiovascular) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Congestive Heart Failure (Heart Failure) (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Congestive Heart Failure (Heart Failure) (Cardiovascular)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Congestive Heart Failure (Heart Failure) (Cardiovascular).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Content: Key Points
Table of Contents 2
Introduction 5
Congestive Heart Failure (Heart Failure) - Overview 6
Congestive Heart Failure (Heart Failure) - Therapeutics Development 7
Congestive Heart Failure (Heart Failure) - Therapeutics Assessment 26
Congestive Heart Failure (Heart Failure) - Companies Involved in Therapeutics Development 40
Congestive Heart Failure (Heart Failure) - Drug Profiles 75
Congestive Heart Failure (Heart Failure) - Dormant Projects 360
Congestive Heart Failure (Heart Failure) - Discontinued Products 366
Congestive Heart Failure (Heart Failure) - Product Development Milestones 368
…Continued
ACCESS REPORT @ https://www.wiseguyreports.com/reports/1705798-congestive-heart-failure-heart-failure-pipeline-review-h2-2017
Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts
Contact Info:
Name: NORAH TRENT
Email: [email protected]
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +44 208 133 9349
Source URL: http://marketersmedia.com/heart-failure-pharmaceutical-and-healthcare-pipeline-review-h2/228662
For more information, please visit http://www.wiseguyreports.com
Source: MarketersMedia
Release ID: 228662
More than 25 years after introducing the world to Artemis Fowl, author Eoin Colfer is teaming up with Disney for an animated series adaptation. On Sunday at New York Comic-Con, Colfer announced during the “25 Years of Artemis Fowl” panel that the series has been greenlit for Disney Channel and Disney+, and he will serve […]
“Digger” will go down in box office history for all the wrong reasons. Tom Cruise and director Alejandro González Iñárritu’s R-rated environmental satire is tracking to lose $245 million in its theatrical run, according to knowledgeable sources. It will wind up as one of the biggest flops, not just of the year but potentially of […]
Chappell Roan returned to the place that inspired one of her biggest hits! The 28-year-old singer was among the stars […] The post Chappell Roan Celebrates ‘Pink Pony Club’ at the West Hollywood Bar That Inspired Her Hit Song appeared first on Just Jared - Celebrity News, Entertainment News & Photos.
Meghan Markle and Prince Harry’s little ones are adjusting to their new life across the pond. After all, the Duchess of Sussex shared an adorable video of their kids Archie, 7, and Lilibet, 5,...
The Bend Film Festival wraps on Sunday after presenting awards for the 23rd edition of the cinematic spectacle in central Oregon. Ramzi Bashour’s debut feature Hot Water, starring Lubna Azabal (Coriolanus), Daniel Zolghadri (Funny Pages), and Dale Dickey (Widow’s Bay), won Best Narrative Feature. The filmmaker, born in Lebanon and based in New York City, […]
Fourteen authors in the New Directions stable have received the Nobel Prize in Literature, including this year and last. How does this small press pack such a punch?
Neon’s Cannes Palme d’Or-winning drama Fjord starring Sebastian Stan and Renate Reinsve had a terrific $124k opening on four screens in New York and Los Angeles, as documentary Naza marks a strong week two expansion. Cristian Mungiu’s Fjord is the director’s second Palme d’Or for Mungiu and the seventh consecutive win for Neon. The film […]
Meghan Markle is sharing another rare look at her family life! The 45-year-old Duchess of Sussex posted a new video […] The post Meghan Markle Shares Rare New Video of Archie & Lilibet Enjoying Life in the UK After Family’s Move appeared first on Just Jared - Celebrity News, Entertainment News & Photos.
Alex Gibney, director of the 3-hour-and-45-minute Elon Musk-centered documentary “Musk,” discussed the lengths he went to to interview the tech billionaire for the film and why he believes Universal Pictures hesitated to plan an international release in a new interview with The New York Times. Although Musk does not appear in the film (though Gibney […]
Globo has sold to the BBC “Blood Red – Under the Moonlight,” a teen werewolf/vampire love triangle thriller now bound for BBC iPlayer and BBC Three. The biggest new announcement set for a packed Mipcom Globo Showcase on Sunday evening, the BBC deal marks a milestone for Globo streaming service Globoplay, the first time a […]
From a beloved dystopian franchise to a 2006 comfort comedy The post The 3 Best New Movies to Watch on Hulu This Week appeared first on TheWrap.
Dhar Mann took center stage at MIPCOM on Sunday for the market’s first-ever pre-opening headline session. He broke down the vision for his soon-to-open studio site, Creator City. Mann founded Dhar Mann Studios and recently announced Creator City, a four-acre campus in L.A. with multiple sound stages and, he said, 175 sets able to house […]
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.